Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H19NO3 |
Molecular Weight | 297.3484 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C2[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3C)[C@H]1O5
InChI
InChIKey=ZKLXUUYLEHCAMF-UUWFMWQGSA-N
InChI=1S/C18H19NO3/c1-19-8-7-18-11-4-6-14(21-2)17(18)22-16-13(20)5-3-10(15(16)18)9-12(11)19/h3-6,12,17,20H,7-9H2,1-2H3/t12-,17+,18+/m1/s1
Molecular Formula | C18H19NO3 |
Molecular Weight | 297.3484 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist. | 2001 May |
|
RNAi-mediated replacement of morphine with the nonnarcotic alkaloid reticuline in opium poppy. | 2004 Dec |
|
Submolecular partitioning of morphine hydrate based on its experimental charge density at 25 K. | 2005 Aug |
|
Cinnamoyl derivatives of 7alpha-aminomethyl-6,14-endo-ethanotetrahydrothebaine and 7alpha-aminomethyl-6,14-endo-ethanotetrahydrooripavine and related opioid ligands. | 2007 Oct 18 |
|
Live cell monitoring of mu-opioid receptor-mediated G-protein activation reveals strong biological activity of close morphine biosynthetic precursors. | 2007 Sep 14 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:08:23 GMT 2025
by
admin
on
Mon Mar 31 22:08:23 GMT 2025
|
Record UNII |
575AOU51CR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
9330
Created by
admin on Mon Mar 31 22:08:23 GMT 2025 , Edited by admin on Mon Mar 31 22:08:23 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
467-04-9
Created by
admin on Mon Mar 31 22:08:23 GMT 2025 , Edited by admin on Mon Mar 31 22:08:23 GMT 2025
|
PRIMARY | |||
|
DTXSID10196908
Created by
admin on Mon Mar 31 22:08:23 GMT 2025 , Edited by admin on Mon Mar 31 22:08:23 GMT 2025
|
PRIMARY | |||
|
m8232
Created by
admin on Mon Mar 31 22:08:23 GMT 2025 , Edited by admin on Mon Mar 31 22:08:23 GMT 2025
|
PRIMARY | Merck Index | ||
|
5462306
Created by
admin on Mon Mar 31 22:08:23 GMT 2025 , Edited by admin on Mon Mar 31 22:08:23 GMT 2025
|
PRIMARY | |||
|
8324
Created by
admin on Mon Mar 31 22:08:23 GMT 2025 , Edited by admin on Mon Mar 31 22:08:23 GMT 2025
|
PRIMARY | |||
|
ORIPAVINE
Created by
admin on Mon Mar 31 22:08:23 GMT 2025 , Edited by admin on Mon Mar 31 22:08:23 GMT 2025
|
PRIMARY | |||
|
207-385-6
Created by
admin on Mon Mar 31 22:08:23 GMT 2025 , Edited by admin on Mon Mar 31 22:08:23 GMT 2025
|
PRIMARY | |||
|
575AOU51CR
Created by
admin on Mon Mar 31 22:08:23 GMT 2025 , Edited by admin on Mon Mar 31 22:08:23 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY | |||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|